FRAMINGHAM (10/22/2003) - Eight new Regional Centers of Excellence (RCEs) for Biodefense and Emerging Infectious Diseases Research are in the works, thanks to US$350 million in grants from the U.S. National Institute of Allergy and Infectious Diseases (NIAID). NIAID will distribute the grant over five years and administer the nationwide group of multidisciplinary research centers that will study both bioterrorism agents and naturally occurring infectious diseases, such as West Nile virus and drug-resistant pathogens. Each RCE will comprise a lead institution and affiliated institutions in the same geographical region. The eight lead institutions are Duke University; Harvard Medical School; The University of Chicago; University of Maryland at Baltimore; The University of Texas Medical Branch; University of Washington at Seattle; Washington University in St. Louis; and the New York State Department of Health.
- Free Whitepaper! The 5 criteria to help you select the right analytics platform for your organization.
- Free Whitepaper! Learn how IT is evolving from producer to enabler, and fostering collaboration around analytics.
- Free Whitepaper! Learn how to create an analytics environment that is governed, scalable and self-serve.